Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) Research & Development (2016 - 2026)

Neogen has reported Research & Development over the past 17 years, most recently at $3.8 million for Q1 2026.

  • Quarterly results put Research & Development at $3.8 million for Q1 2026, down 15.56% from a year ago — trailing twelve months through Feb 2026 was $19.8 million (down 0.89% YoY), and the annual figure for FY2025 was $21.1 million, down 6.18%.
  • Research & Development for Q1 2026 was $3.8 million at Neogen, down from $4.6 million in the prior quarter.
  • Over the last five years, Research & Development for NEOG hit a ceiling of $7.3 million in Q1 2023 and a floor of $3.8 million in Q1 2026.
  • Median Research & Development over the past 5 years was $5.1 million (2025), compared with a mean of $5.4 million.
  • Biggest five-year swings in Research & Development: soared 84.13% in 2023 and later tumbled 33.14% in 2024.
  • Neogen's Research & Development stood at $6.8 million in 2022, then fell by 15.92% to $5.8 million in 2023, then dropped by 11.26% to $5.1 million in 2024, then dropped by 10.67% to $4.6 million in 2025, then dropped by 16.72% to $3.8 million in 2026.
  • The last three reported values for Research & Development were $3.8 million (Q1 2026), $4.6 million (Q4 2025), and $5.1 million (Q3 2025) per Business Quant data.